VPRIV 400 UNT Injection
- RxCUI
- 901812
- RxNorm name
- VPRIV 400 UNT Injection
- Display name
- VPRIV 400 UNT Injection
- Full name
- VPRIV 400 UNT Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022575 | VPRIV | velaglucerase alfa | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VPRIV | VELAGLUCERASE ALFA | Takeda Pharmaceuticals America, Inc. | ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 901812 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf | VPRIV 400 UNT Injection [PSN] · velaglucerase alfa 400 UNT Injection [Vpriv] [SBD] · Vpriv 400 UNT Injection [SY] | 3 | 27 | These highlights do not include all the information needed to use VPRIV safely and effectively. See full prescribing information for VPRIV. VPRIV ® (velaglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2010 | 20241126 |